(Q53580804)
Statements
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. (English)
Cheri Enders Klein
Yi-Lin Chiu
Walid Awni
Tong Zhu
Renee S Heuser
Thao Doan
Joerg Breitenbach
John B Morris
Scott C Brun
George J Hanna
1 April 2007
44
4
401-410